Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Lenalidomide
Malignant Pancreatic Neoplasm
Shandong Cancer Hospital and InstituteP2B (59)
Levofolinic Acid
Biliary Tract Cancer
Shenzhen Xinhe BiomedicalP2B (59)
Lurbinectedin
Cancer
Jazz PharmaceuticalsP2B (59)
Mesna
Chronic Myeloid Leukemia
Center for International Blood and Marrow Transplant ResearchP2B (59)
Methotrexate
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP2B (59)
Methotrexate
Hematologic Disorder
University of Michigan Rogel Cancer CenterP2B (59)
Methotrexate
Myelodysplastic Syndrome With Excess Blasts-1
Fred Hutchinson Cancer CenterP2B (59)
Methotrexate
Paroxysmal Nocturnal Hemoglobinuria
Fred Hutchinson Cancer CenterP2B (59)
Methotrexate
Shwachman-Diamond Syndrome
Fred Hutchinson Cancer CenterP2B (59)
Nadravaleucel
Non-Hodgkin Lymphoma
David WaldP2B (59)
Niraparib
ATM-Related Cancer Predisposition
University of California, San FranciscoP2B (59)
Niraparib
HER2 Positive Breast Carcinoma
University of Alabama at BirminghamP2B (59)
Niraparib
Ovarian Serous Adenocarcinoma
Sunnybrook Health Sciences CentreP2B (59)
Niraparib
PALB2-Related Cancer Predisposition
Qian QinP2B (59)
Niraparib
Endometrial Carcinoma
University of OklahomaP2B (59)
Nivestim
Alzheimer Disease
University of Colorado, DenverP2B (59)
Nivestim
Gastric Cancer
Mayo ClinicP2B (59)
Nivolumab
Gastric Adenocarcinoma
National University Hospital, SingaporeP2B (59)
Nivolumab
Glioma
Jason J. Luke, MDP2B (59)
Nivolumab
Pancreatic Ductal Adenocarcinoma
Georgetown UniversityP2B (59)
Nivolumab
Rectal Carcinoma
University of Colorado, DenverP2B (59)
Nivolumab
Rhabdomyosarcoma
Children's National Research InstituteP2B (59)
Nivolumab
Sarcoma
Tempest TherapeuticsP2B (59)
o6-benzylguanine
Gliosarcoma
Leland MethenyP2B (59)
Obinutuzumab
High Grade B-Cell Lymphoma
National Cancer Institute (NCI)P2B (59)
Showing 2376 to 2400 of 13,155 assets
PreviousPage 96 of 527Next